Literature DB >> 34183458

Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia.

Clement Delage1,2, Hélène Lelong3,4, Francoise Brion2, Jacques Blacher3,4.   

Abstract

OBJECTIVES: In recent years, hospital pharmacists have gained more importance in the clinical support of patients. However, most of the studies evaluating the impact of clinical pharmacy have only studied patients' adherence or satisfaction. The aim of this study was to evaluate the direct clinical outcomes of a pharmacist-led educational intervention in patients with chronic disease.
METHODS: We conducted a randomised, controlled, parallel, physician-blinded study in a day hospital and a consultation unit of a French teaching hospital over a 1-year period. Patients with hypertension, type 2 diabetes or hypercholesterolaemia who did not reach their therapeutic goals despite drug therapy were eligible. Patients in the intervention group received an intervention from a hospital pharmacist who provided patient education on pathology and drug management. The primary outcome was the proportion of patients reaching their therapeutic goals for blood pressure, glycated haemoglobin level or low-density lipoprotein cholesterol level at the 3-month follow-up consultation.
RESULTS: From January to December 2015, 89 patients were included and 73 completed the study. In the intervention group, 61.7% (21/34) of the patients reached their therapeutic goals compared with 33.3% (13/39) in the control group (p=0.015). The intervention was significantly more effective in polypharmacy patients (60.0% (12/20) vs 16.7% (4/24); p=0.005), in those aged >60 years (57.9% (11/19) vs 26.1% (6/23); p=0.037) and in patients with a high education level (68.8% (11/16) vs 29.4% (5/17); p=0.024).
CONCLUSION: A single pharmacist-led educational intervention has a clinical impact, doubling the proportion of patients reaching their therapeutic goals at 3 months, especially in polypharmacy patients and those aged >60 years. This study confirms the value of clinical involvement of hospital pharmacists in patient care in a consultation unit and day hospital. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical pharmacy; continuing; education; hospital; hypertension; pharmacy; pharmacy service

Mesh:

Year:  2021        PMID: 34183458      PMCID: PMC8640406          DOI: 10.1136/ejhpharm-2021-002787

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  33 in total

1.  Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation.

Authors:  Luciana Carla Chiapella; Jorgelina Montemarani Menna; María Eugenia Mamprin
Journal:  Int J Clin Pharm       Date:  2018-06-07

2.  Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.

Authors:  Jean-Pierre Jourdan; Alexandra Muzard; Isabelle Goyer; Yann Ollivier; Youssef Oulkhouir; Patrick Henri; Jean-Jacques Parienti; Cécile Breuil
Journal:  Int J Clin Pharm       Date:  2018-10-26

Review 3.  Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Abdullah A Alshehri; Zahraa Jalal; Ejaz Cheema; M Sayeed Haque; Duncan Jenkins; Asma Yahyouche
Journal:  Br J Clin Pharmacol       Date:  2020-01-03       Impact factor: 4.335

4.  Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and meta-analysis.

Authors:  Lina Mohammad Naseralallah; Tarteel Ali Hussain; Myriam Jaam; Shane Ashley Pawluk
Journal:  Int J Clin Pharm       Date:  2020-04-24

5.  A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.

Authors:  Susan M Abughosh; Xin Wang; Omar Serna; Chris Henges; Santhi Masilamani; Ekere James Essien; Nancy Chung; Marc Fleming
Journal:  J Manag Care Spec Pharm       Date:  2016-01

Review 6.  Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK.

Authors:  Nina L Barnett
Journal:  Br J Clin Pharmacol       Date:  2019-05-27       Impact factor: 4.335

Review 7.  Effect of medication dosing frequency on adherence in chronic diseases.

Authors:  Sameer D Saini; Philip Schoenfeld; Kellee Kaulback; Marla C Dubinsky
Journal:  Am J Manag Care       Date:  2009-06-01       Impact factor: 2.229

8.  Assessing medication adherence: options to consider.

Authors:  Audrey Lehmann; Parisa Aslani; Rana Ahmed; Jennifer Celio; Aurelie Gauchet; Pierrick Bedouch; Olivier Bugnon; Benoît Allenet; Marie Paule Schneider
Journal:  Int J Clin Pharm       Date:  2013-10-29

9.  [Does the duration of medical consultations have an impact on the prescription of psychotropic drugs? Cross-sectional study carried out in general practice on 2,896 procedures].

Authors:  Olivier Kandel; Audrey Ripault; Maud Jourdain; Gauthier Bouche
Journal:  Rev Prat       Date:  2008-06-30

10.  Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department.

Authors:  Pierre Renaudin; Annabelle Coste; Yohan Audurier; Julie Berbis; François Canovas; Anne Jalabert; Audrey Castet-Nicolas; Gregoire Mercier; Maxime Villiet; Louis Dagneaux; Cyril Breuker
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.844

View more
  1 in total

1.  Effectiveness of Community Pharmacy Diabetes and Hypertension Care Program: An Unexplored Opportunity for Community Pharmacists in Pakistan.

Authors:  Madeeha Malik; Azhar Hussain; Usman Aslam; Ayisha Hashmi; Mojtaba Vaismoradi; Khezar Hayat; Shazia Jamshed
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.